| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
5,960,000
|
5,553,000
|
6,700,000
|
6,484,000
| | Cost of Revenue | 3,587,000 | 3,346,000 | 3,951,000 | 3,856,000 | | |
Gross Profit
|
2,373,000
|
2,207,000
|
2,749,000
|
2,628,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 1,485,000 | 1,480,000 | 1,507,000 | 1,422,000 |
|
Non Recurring |
-
|
-
| 592,000 |
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
888,000
|
727,000
|
650,000
|
1,206,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 888,000 | 727,000 | 650,000 | 1,206,000 |
|
Interest Expense | 57,000 | 54,000 | 57,000 | 51,000 |
|
Income Before Tax | 831,000 | 673,000 | 593,000 | 1,155,000 |
|
Income Tax Expense | 253,000 | 207,000 | 293,000 | 368,000 |
|
Minority Interest | (17,000) | (12,000) | (18,000) | (17,000) |
|
|
|
Net Income From Continuing Ops | 561,000 | 454,000 | 338,000 | 770,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
561,000
|
454,000
|
338,000
|
770,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
561,000
|
454,000
|
282,000
|
770,000
|
|